<noframes id="loIgfyA"><output id="loIgfyA"></output></noframes><li id="loIgfyA"></li><nav id="loIgfyA"><xmp id="loIgfyA"><sub id="loIgfyA"></sub><wbr id="loIgfyA"><noframes id="loIgfyA"><wbr id="loIgfyA"></wbr><wbr id="loIgfyA"><noframes id="loIgfyA"><wbr id="loIgfyA"></wbr>
<wbr id="loIgfyA"></wbr><wbr id="loIgfyA"></wbr>
<tbody id="loIgfyA"><center id="loIgfyA"></center></tbody><wbr id="loIgfyA"></wbr>
<tbody id="loIgfyA"></tbody>
  • <tbody id="loIgfyA"><center id="loIgfyA"></center></tbody><sub id="loIgfyA"></sub><sub id="loIgfyA"><xmp id="loIgfyA"><tbody id="loIgfyA"><noframes id="loIgfyA">
  • <wbr id="loIgfyA"><noframes id="loIgfyA"><sub id="loIgfyA"></sub><wbr id="loIgfyA"></wbr>
  • <tbody id="loIgfyA"></tbody>
  • <wbr id="loIgfyA"><li id="loIgfyA"></li></wbr>
  • <nav id="loIgfyA"><xmp id="loIgfyA"><sub id="loIgfyA"></sub>
  • <sub id="loIgfyA"><xmp id="loIgfyA">
  • <wbr id="loIgfyA"></wbr>
  • <sub id="loIgfyA"><xmp id="loIgfyA"><wbr id="loIgfyA"><noframes id="loIgfyA"><center id="loIgfyA"></center>
  • Create Account | Sign In: Author or Forum

    Search Symptoms

    Medical Specialty >>


    1:03 PM CDT. Read article More News


    Home Hazard Removal Program Cuts Rate of Falls Among Elderly

    7:46 PM CDT.

    While the program did not reduce the hazard of falls, authors say it nonetheless may be an important,…


    September 2020 Briefing - Pharmacy

    October 01, 2020. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.


    Immunotherapy with Checkpoint Inhibitors in Triple Negative Breast Cancer (TNBC)

    Karima Oualla, MD. Dr. Karima Oualla discusses recent advances on the use of checkpoint inhibitors in the treatment of triple negative breast cancer (TNBC). Dr. Oualla is an International expert in breast cancer and is the primary author of the manuscript entitled "Novel therapeutic strategies in the treatment of triple-negative…

    Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial

    Robert L. Coleman, MD. Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…

    Investigational Topical Minocycline Gel for Acne Advances to Phase III Development

    Ted Lain, MD. Clinical trial investigator Dr. Ted Lain ments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…


    Acute dyspnea (shortness of breath)

    By Tamer M. Fouad, M.D.

    Dyspnea (shortness of breath) is a term used to characterize a subjective experience of breathing disfort that is prised of qualitatively distinct…


    RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development

    By namabc

    As I understand, this is a great step of development that we can use to save many people from horrible diseases. and i also hope Dr.Lain and your partners…


    Sunday Times - Doctors Lounge Voted top 10 best ‘Ask an expert’ website

    Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.

    <nav id="loIgfyA"><xmp id="loIgfyA"><nav id="loIgfyA"></nav><nav id="loIgfyA"><xmp id="loIgfyA">
  • <wbr id="loIgfyA"></wbr>
  • <wbr id="loIgfyA"></wbr><wbr id="loIgfyA"></wbr>
  • <var id="loIgfyA"></var>
    <wbr id="loIgfyA"></wbr>
  • <tbody id="loIgfyA"><noframes id="loIgfyA"><wbr id="loIgfyA"></wbr><sub id="loIgfyA"></sub>
    <tbody id="loIgfyA"></tbody>
    <wbr id="loIgfyA"></wbr>
  • <sub id="loIgfyA"></sub>
  • <sub id="loIgfyA"><progress id="loIgfyA"></progress></sub>
  • <nav id="loIgfyA"></nav>
  • <sub id="loIgfyA"><xmp id="loIgfyA"><nav id="loIgfyA"><xmp id="loIgfyA"><nav id="loIgfyA"><progress id="loIgfyA"></progress></nav><sub id="loIgfyA"><xmp id="loIgfyA"><sub id="loIgfyA"><progress id="loIgfyA"></progress></sub>
  • <sub id="loIgfyA"></sub><wbr id="loIgfyA"></wbr>
  • 友情鏈接:

      青青草原老司机 亚洲Av一级在线播放 天天干天天干天天操 国产福利视频第一导航 天天射日日 一级黄色电视美国一级黄色电视